{"title":"Localized amyloid-β oligomers in the lateral entorhinal cortex drives olfactory dysfunction through aberrant neuronal and network activity.","authors":"Ting Pan, Jiaxing Fang, Xiao Wang, Yimeng Chen, Shan Li, Gaoxue Qiu, Changcheng Sun, Chao Liu, Anan Li, Fengjiao Chen","doi":"10.1186/s40478-026-02354-3","DOIUrl":null,"url":null,"abstract":"<p><p>Olfactory dysfunction is one of the most common early features of Alzheimer's disease (AD), yet its underlying neural mechanisms remains unclear. The lateral entorhinal cortex (LEC), a central node in the olfactory network, is among the earliest regions affected by AD pathology. However, the direct evidence supporting a causal link between LEC dysfunction and olfactory disorders in early AD is limited. In the present study, we explored whether and how LEC dysfunction contributes to early AD olfactory dysfunction by injecting amyloid-β<sub>1-42</sub> (Aβ<sub>1-42</sub>) oligomers into the LEC to induce localized Aβ oligomers accumulation in this region. Our data demonstrate that localized Aβ oligomers in the LEC impaired odor detection and discrimination in mice. In vivo recordings revealed that Aβ oligomers increased baseline firing and odor-evoked activity in LEC neurons, while also enhancing odor-evoked beta oscillations. This hyperactive state corresponded with disrupted population-level odor decoding. Furthermore, deficits in synaptic structure and impaired synaptic transmission likely underlie the observed behavioral dysfunctions. Overall, these findings indicate that LEC dysfunction is linked to olfactory deficits in early AD, providing direct evidence for the involvement of this region in AD-related olfactory impairment.</p>","PeriodicalId":6914,"journal":{"name":"Acta Neuropathologica Communications","volume":" ","pages":""},"PeriodicalIF":6.5000,"publicationDate":"2026-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13548545/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neuropathologica Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40478-026-02354-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Olfactory dysfunction is one of the most common early features of Alzheimer's disease (AD), yet its underlying neural mechanisms remains unclear. The lateral entorhinal cortex (LEC), a central node in the olfactory network, is among the earliest regions affected by AD pathology. However, the direct evidence supporting a causal link between LEC dysfunction and olfactory disorders in early AD is limited. In the present study, we explored whether and how LEC dysfunction contributes to early AD olfactory dysfunction by injecting amyloid-β1-42 (Aβ1-42) oligomers into the LEC to induce localized Aβ oligomers accumulation in this region. Our data demonstrate that localized Aβ oligomers in the LEC impaired odor detection and discrimination in mice. In vivo recordings revealed that Aβ oligomers increased baseline firing and odor-evoked activity in LEC neurons, while also enhancing odor-evoked beta oscillations. This hyperactive state corresponded with disrupted population-level odor decoding. Furthermore, deficits in synaptic structure and impaired synaptic transmission likely underlie the observed behavioral dysfunctions. Overall, these findings indicate that LEC dysfunction is linked to olfactory deficits in early AD, providing direct evidence for the involvement of this region in AD-related olfactory impairment.
期刊介绍:
"Acta Neuropathologica Communications (ANC)" is a peer-reviewed journal that specializes in the rapid publication of research articles focused on the mechanisms underlying neurological diseases. The journal emphasizes the use of molecular, cellular, and morphological techniques applied to experimental or human tissues to investigate the pathogenesis of neurological disorders.
ANC is committed to a fast-track publication process, aiming to publish accepted manuscripts within two months of submission. This expedited timeline is designed to ensure that the latest findings in neuroscience and pathology are disseminated quickly to the scientific community, fostering rapid advancements in the field of neurology and neuroscience. The journal's focus on cutting-edge research and its swift publication schedule make it a valuable resource for researchers, clinicians, and other professionals interested in the study and treatment of neurological conditions.